Journals / Türk Anestezi ve Reanimasyon Dergisi / 2011 / Cilt: 39 - Sayı: 5

Guillain-Barre Syndrome in pregnancy: case report

Gebelikte Guillain-Barre sendromu

Pages
281–284
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we discussed the diagnosis and treatment modalities and intensive care approaches in a 26 year old pregnant patient with Guillain Barre Syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Guillain Barre Syndrome is an acute inflammatory demyelinating polyneuropathy and it is a rare event in pregnancy.
📊
Key Findings & Data:Active treatment such as plasmapheresis and intravenous immunoglobulin together with vigilant follow up in intensive care has improved maternal and fetal outcome.
💡
Conclusion & Impact:In this case report, we discussed the diagnosis and treatment modalities and intensive care approaches in a 26 year old pregnant patient with Guillain Barre Syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Guillain Barre Syndrome is an acute inflammatory demyelinating polyneuropathy and it is a rare event in pregnancy. Active treatment such as plasmapheresis and intravenous immunoglobulin together with vigilant follow up in intensive care has improved maternal and fetal outcome. In this case report, we discussed the diagnosis and treatment modalities and intensive care approaches in a 26 year old pregnant patient with Guillain Barre Syndrome.

Özet

Guillain-Barre Sendromu akut inflamatuvar demiyelizan bir polinöropatidir. Gebelikte ender görülen bir hastalıktır. Plazmaferez, intravenöz immunoglobulin gibi tedavi yöntemleri ve yoğun bakımda yakın takip ile daha iyi maternal ve fetal sonuçlar alınmaktadır. Bu olgu sunumunda, 26 yaşında gebede Guillain-Barre sendromu tanı ve tedavi modaliteleri ve yoğun bakım yaklaşımları tartışıldı.

🔖

Cite This Article

KARAHAN, M. A., KÖYLÜOĞLU, A. C., YALÇIN, Ş., AYDOĞAN, H., ÖZKUL, M. Y. (2022). Guillain-Barre Syndrome in pregnancy: case report. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 39 - Sayı: 5, 281–284. https://ajindex.com/articles/619852

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Hughes RA, Cornblath DR. Gullian Barre syndrome. Lancet 2005;366:1653-66.
  2. Cheng Q, Jiang GX, Fredrikson S, Link H, de Pedro-Cuesta J. Increased incidence of Guillain-Barre Syndrome Postpartum. Epidemiology 1998;9:601-4. http://dx.doi.org/10.1097/00001648-199811000-00006 PMid:9799167 3. Chan LY, Tsui MH, Leung TN. Guillain-Barré Syndrome in Pregnancy. Acta Obstet Gynecol Scand 2004;83:319-25. PMid:15005776 4. Nelson LH, McLean WT. Management of Landry-Guillain-Barre´ syndrome in pregnancy. Obstet Gynecol 1985;65:25-9
  3. The Italian Guillain-Barre´ Study Group. The prognosis and main prognostic indicators of Guillain-Barre´ syndrome: a multicentre prospective study of 297 patients. Brain 1996;119:2053-61. http://dx.doi.org/10.1093/brain/119.6.2053 PMid:9010009 6. Caudle MR, Scott JR. The potential role of immunosuppression plasmapheresis, and desensitization as treatment modalities for RH immunization. Clin Obstet Gynecol 1982;25:313-9. http://dx.doi.org/10.1097/00003081-198206000-00011 PMid:6179680 7. Nazlıel B. Guillain-Barre Sendromu. Türkiye Klinikleri 2006;2:105-10
  4. Dalakas MC. Intravenous immunoglobulin in autoimmune neuromusculer diseaese. JAMA 2004;291:2367-75. http://dx.doi.org/10.1001/jama.291.19.2367 PMid:15150209 9. Branch DW, Porter TF, Paidas MJ, Belfort MA, Gonik B. Obstetrics uses of intravenous immunoglobulin: successes,failures,and promises. J Allergy Clin Immunol 2001;108:133-8. http://dx.doi.org/10.1067/mai.2001.117821 PMid:11586281